Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain

被引:53
|
作者
Petzold, Axel
Shaw, Gerry
机构
[1] UCL, Dept Neuroimmunol, Inst Neurol, London WC1N 3BG, England
[2] Univ Florida, Coll Med, Dept Neurosci, Evelyn F & William L McKnight Brain Inst, Gainesville, FL 32611 USA
关键词
neurofilament; NfH; NF-H; pNfH; biomarker;
D O I
10.1016/j.jim.2006.09.021
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Recent studies suggest that the quantification of neurofilament subunits in cerebrospinal fluid (CSF), blood and amniotic fluid may reflect neuroaxonal damage and be of high clinical value. The present study aims to cross-validate two different independently developed ELISA techniques for the quantification of the phosphorylated axonal forms of the neurofilament heavy chain (pNfH). Methods: The London ELISA method is based on barbitone buffer and the commercially available SM135 capture antibody. The Gainesville method uses Tris-buffered saline (TBS) and an affinity purified chicken polyclonal capture antibody (C-pNfH). Coded CSF from 50 patients with neurological diseases were analyzed in duplicate by both laboratories, each using both ELISA methods, but with each lab using their own detection antibody, tertiary antibody and chromogen. Methods were compared using Bland Altman plots. Correlation and regression analyses were used to allow for transformation of values between both methods. Results: The Bland-Altman plots demonstrated that 96% of all samples fell into the narrow 95% limits of agreement (0.04 units of OD). There was a high correlation (Spearman R = 0.92, p < 0.0001 and Pearson R = 0.98, p < 0.0001) between the Gainesville (1) and the London (X) method with Y=0.132+1.104*X. The previously determined upper reference limit of 0.73 mg/l (London method) corresponds to 0.94 mg/l for the Gainesville method. CSF pNfH levels above the reference limit were observed in patients with encephalitis, encephalomyelitis, hydrocephalus, subarachnoid haemorrhage, spino-muscular atrophy, stroke and cancer with both methods agreeing in all cases. Conclusion: The two assays are in excellent agreement, suggesting that pNfH, which has a number of unusual protein chemical features, may be the biomarker of choice for the routine and robust detection of axonal injury and degeneration in both research and clinical contexts. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 50 条
  • [41] Diagnostic and prognostic role of plasma phosphorylated neurofilament heavy chain (pNf-H) in amyotrophic lateral sclerosis
    Dell'Abate, Maria Teresa
    Zecca, Chiara
    Pasculli, Giuseppe
    Barone, Roberta
    Capozzo, Rosa
    Barulli, Maria Rosaria
    Arima, Serena
    Pollice, Alessio
    Tortelli, Rosanna
    Logroscino, Giancarlo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 257 - 257
  • [42] Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
    De Schaepdryver, Maxim
    Jeromin, Andreas
    Gille, Benjamin
    Claeys, Kristl G.
    Herbst, Victor
    Brix, Britta
    Van Damme, Philip
    Poesen, Koen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (04): : 367 - 373
  • [43] Preoperative detection of serum phosphorylated neurofilament heavy chain subunit predicts postoperative delirium: a prospective observational study
    Mietani, Kazuhito
    Hasegawa-Moriyama, Maiko
    Yagi, Kouichi
    Inoue, Reo
    Ogata, Toru
    Kurano, Makoto
    Shimojo, Nobutake
    Seto, Yasuyuki
    Sumitani, Masahiko
    Uchida, Kanji
    JOURNAL OF GERONTOLOGY AND GERIATRICS, 2022, 70 (03): : 169 - 177
  • [44] Comparison of two methods for measuring orientation
    Geraets, WGM
    BONE, 1998, 23 (04) : 383 - 388
  • [45] Evaluation of neurofilament heavy chain levels in progressive multiple sclerosis patients: preliminary results
    Kaymakamzade, B.
    Kurne, A. Tuncer
    Tumani, H.
    Lehmensiek, V.
    Sayat, G.
    Karabudak, R.
    JOURNAL OF NEUROLOGY, 2014, 261 : S453 - S453
  • [46] Evaluation of neurofilament heavy chain levels in progressive multiple sclerosis patients: preliminary results
    Kaymakamzade, B.
    Kurne, A. Tuncer
    Tumani, H.
    Lehmensiek, V.
    Sayat, G.
    Karabudak, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 697 - 697
  • [47] Remodeling of the neuromuscular junction in myasthenia gravis increases serum neurofilament heavy chain levels
    Wong, Sui H.
    Petzold, Axel
    MUSCLE & NERVE, 2023, 68 (01) : 91 - 94
  • [48] Comparison of neurofilament light chain results between two independent facilities
    Sejbaek, Tobias
    Mendoza, Jason P.
    Penner, Natasha
    Madsen, Jonna Skov
    Olsen, Dorte Aalund
    Illes, Zsolt
    BMJ NEUROLOGY OPEN, 2020, 2 (02)
  • [49] Elevated levels of phosphorylated neurofilament heavy subunit in the cerebrospinal fluid of patients with lumbar spinal stenosis: preliminary findings
    Ohya, Junichi
    Chikuda, Hirotaka
    Kato, So
    Hayakawa, Kentaro
    Oka, Hiroyuki
    Takeshita, Katsushi
    Tanaka, Sakae
    Ogata, Toru
    SPINE JOURNAL, 2015, 15 (07): : 1587 - 1592
  • [50] Original Serum Phosphorylated Neurofilament Heavy Subunit Levels and its Association with the Risk for Catastrophic Injury in Thoroughbred Racehorses
    Rojas-Nunez, Irene
    Gomez, Adriana Morales
    Palmer, Scott
    Mohammed, Hussni O.
    JOURNAL OF EQUINE VETERINARY SCIENCE, 2022, 116